Stock Ticker

  • Loading stock data...

Sandoz Of Novartis AG (NYSE:NVS) Acquires Antibiotics Of GlaxoSmithKline Plc (NYSE:GSK) For $500 Million

Novartis AG (NYSE:NVS)’s Sandoz entered a deal with GlaxoSmithKline Plc (NYSE:GSK) to acquire the established antibiotic brands like Fortum, Zinacef, and Zinnat for $350 million. GlaxoSmithKline will also receive milestone payments of up to $150 million. The deal will be closed by the end of this year. Sandoz decided to purchase antibiotics brands after it […]

Stocks for the Pandemic Long Haul (FLGT, ALST, HOLX)

Scientists are beginning to arrive at the notion that the fight with Covid-19 is not a short raging battle that will be over by summer 2021 but a long-term war that will be waged for many years to come, with a constant need for PPE, testing, vaccine rejiggering, specialized air filtration solutions, and other ‘coping’ […]

Pfizer (NYSE:PFE) To Continue Supplying COVID-19 Vaccine In Italy Even As Rome Threatens To Sue

Pfizer (NYSE:PFE) has indicated that it will continue supplying its COVID-19 vaccine to Italy as per the European Commission agreement even as the government considers suing the group’s CEO of the Italian unit. Rome is planning to sue the US pharmaceutical company for falling behind in deliveries of the COVID-19 vaccine. Italy considering suing Pfizer […]

Novartis (NYSE:NVS) Enters Agreement For Manufacture Of Pfizer Inc. (NYSE:PFE) And BioNTech’s (NASDAQ:BNTX) mRNA Vaccine

Novartis (NYSE:NVS) has entered an initial agreement with Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) for manufacturing support to boost production of their mRNA COVID-19 vaccine to help address supply shortages. This is an example of an unlikely collaboration between big pharmaceutical companies geared at the fight against the coronavirus pandemic. Novartis signs vaccine manufacturing […]

Seelos Therapeutics Inc. (NASDAQ:SEEL) Announce Inclusion Of SLS-005 Study In The HEALEY ALS Platform Trial

Seelos Therapeutics Inc. (NASDAQ:SEEL) has announced that its Phase IIb/III SLS-005 (trehalose) study has been selected by Sean M. Healey & AMG Centre for ALS at Massachusetts General Hospital to be part of the HEALEY ALS platform Study. This is the first-ever study platform for amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease) treatment. SLS-005 […]

Novan Inc (NASDAQ:NOVN) Recruits 525 Patients in the Phase 3 Clinical Trial to Treat Molluscum Contagiosum and Expects Topline Results in Q2 2021

Novan Inc (NASDAQ:NOVN) enrolled 525 patients for Simple4 Phase 3 clinical trial. It exceeds 60% enrollment of 825 patients and expects to complete the process in Q1 2021. Treatment for contagious skin infection The main aim of phase 3 clinical trial is to obtain topline efficacy results of the antiviral gel – SB206 to cure […]

Merck (NYSE:MRK) Receives Approval for KEYTRUDA From the EMA As First-Line MSI-H/dMMR Colorectal Cancer Treatment

Merck (NYSE:MRK) has announced that the European Medicines Agency’s Committee for Medicinal Product for Human Use has adopted a positive view recommending KEYTRUDA approval. EMA’s CHMP approves KEYTRUDA as MSI-H/dMMR cancer treatment KEYTRUDA is the company’s anti-PD-1 therapy used as a monotherapy for first-line mismatch repair deficient (dMMR) or metastatic microsatellite instability-high (MSI-H) colorectal cancer […]

FDA Approves Pfizer Inc.’s (NYSE:PFE) Vaccine Candidate for Emergency Use

On Friday, the FDA granted Pfizer Inc.’s (NYSE:PFE) COVID-19 vaccine Emergency Use Authorization, clearing the path for millions of Americans to start receiving the vaccine immediately. Pfizer’s COVID-19 vaccine receives Emergency Use Authorization in the US The approval is a massive turning point considering the COVID-19 pandemic has claimed over 290,000 lives across the US. […]

Novartis AG (NYSE:NVS) Reports First REACH3 Study Data Showing Jakavi®’s Improving Patients Outcomes In chronic GvHD

Novartis AG (NYSE:NVS) has announced its third phase REACH3 study results, which showed that Jakavi® significant failure-free survival improvements in patients with steroid-refractory chronic graft-versus-host disease (GvHD) relative to best available therapy (BAT). Novartis reports positive REACH3 results of Jakavi in chronic GvHD The company presented the REACH3 results at the Annual 62nd American Society […]

Pfizer Inc. (NYSE:PFE) Cuts Its Projected Number Of COVID-19 Vaccines Doses For 2020 Because Of Production Challenges

Pfizer Inc. (NYSE:PFE) has announced that it will ship only half of the initially expected coronavirus vaccine doses this year due to supply chain problems. The company is developing a COVID-19 vaccine in partnership with Germany-based BioNTech SE (NASDAQ:BNTX). Pfizer to deliver 50 million vaccine doses this year The pharmaceutical giant has slashed its initial […]

Johnson & Johnson (NYSE:JNJ) And AstraZeneca (NASDAQ:AZN) To Restart COVID-19 Vaccine Trials

According to Operation Warp Speed head, Johnson & Johnson (NYSE:JNJ) and AstraZeneca (NASDAQ:AZN) could restart their US COVID-19 vaccine trials this week Moncef Slaoui. Halted COVID-19 vaccine trials could restart this week The companies’ COVID-19 vaccine studies were halted due to e-safety concerns after subjects became ill. This slowed the race for a vaccine to […]

Pfizer’s (NYSE:PFE) COVID-19 Trial in Children as Young as 12 Years Draws Mixed Sentiments

Pfizer Inc. (NYSE:PFE) recently announced an expansion to its COVID-19 vaccine trial to include teenagers and children of 12 years. The company is the first drugmaker to include children in their COVID-19 vaccine trials, and this has drawn divided reactions from different people. Pfizer testing vaccine in 3,000 teens The New York Pharms received approval […]

Walmart (NYSE:WMT) Introduces Walmart Insurance Services Offering Medicare Insurance Plans To Seniors And Disabled People

Walmart (NYSE:WMT) has made a move to add Medicare health insurance plans to its list of in-store offerings ahead of the start of the federal program’s Annual Enrolment Period. Walmart launches Walmart Insurance Services for the provision of low-cost insurance plans This is not the first time the retailer has forayed into healthcare as it […]

Pfizer Inc. (NYSE:PFE) And BioNTech SE (NASDAQ:BNTX) Commences COVID-19 Vaccine Trials In Teenagers and Children

Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) have received approval from the FDA to test their COVID-19 vaccine candidate in children beginning from 12 years. According to the trial’s lead researcher already parents have shown interest in enrolling children in the study. Pfizer and BioNTech start testing COVID-19 vaccine in kids The trial’s expansion to […]